Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
Author:
Affiliation:
1. Department of Radiation Oncology, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine
2. Department of Pharmacology, Seoul National University College of Medicine
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.jstage.jst.go.jp/article/bpb/38/7/38_b15-00231/_pdf
Reference45 articles.
1. 1) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin., 61, 69–90 (2011).
2. 2) Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol., 7, 448–458 (2010).
3. 3) Okuda H. Hepatocellular carcinoma development in cirrhosis. Best Pract. Res. Clin. Gastroenterol., 21, 161–173 (2007).
4. 4) Yamashita T, Wang WX. Cancer stem cells in the development of liver cancer. J. Clin. Invest., 123, 1911–1918 (2013).
5. 5) Marquardt JU, Thorgeirsson SS. Snapshot: hepatocellular carcinoma. Cancer Cell, 25, 550.e1 (2014).
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10
2. Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives;Discover Oncology;2024-07-03
3. Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine;Pharmacogenomics and Personalized Medicine;2024-05
4. MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC;American Journal of Cancer Research;2024
5. MicroRNA‐155 downregulates long noncoding RNA prostate cancer‐associated transcript 29 in hepatocellular carcinoma to suppress cancer cell invasion and migration;Journal of Biochemical and Molecular Toxicology;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3